Periodic Reporting for period 3 - EU-RESPONSE (European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases)

The DisCoVeRy trial, a phase 3, multi-arm adaptive trial, was first launched in France in 2020 with the aim of expanding to other European countries and strengthening trial management capacity. The primary objective was to evaluate both repurposed and novel medicines rapidly...